Alternatives
Alternatives to Myfortic 180 mg delayed-release tablet
1 other presentations of Mycophenolate 180 mg delayed-release tablet
There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Mycophenolate), strength (180 mg) and dosage form (delayed-release tablet) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Myfortic 180 mg delayed-release tabletThis pageOral | Novartis Pharmaceuticals | US FDA | 120 tablets | Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F). Protect from moisture. | On request | — | Available on request |
| Mycophenolate 180 mg delayed-release tabletOral | — | US FDA | 500 tablets, 120 tablets | Store at 20 °C to 25°C ( 68 °F to 77°F), excursions permitted from 15° C to 30°C (59° F to 86°F). Protect from moisture. | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Myfortic 180 mg delayed-release tabletNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.